Sanofi S.A.

Sanofi is a France-based biopharma company. It researches, develops and manufactures prescription medicines and vaccines. Its shares trade on Euronext Paris under the ticker SAN.

At the center of its product range are medicines for immune-mediated diseases, rare diseases, neurology and oncology; in immunology, biologic drugs such as Dupixent stand out. The vaccines unit offers products such as flu, meningitis and childhood vaccines. The controlling stake in Opella, which houses over-the-counter consumer health products, was transferred to the private equity firm CD&R in 2025, with Sanofi retaining a minority stake in the company. As a result, the group has moved to a structure focused on prescription medicines and vaccines.

For pharmaceutical companies, clinical trial results, regulatory approvals, the expiry of patent protection, pricing pressures and seasonality in vaccine demand are watched. The Sanofi page on Lzzo.com presents the price of the Paris-listed shares in US dollars and can also show the Turkish lira, euro or pound sterling equivalent; a historical price chart, technical indicators, the data source and the time of the last update are on the page as well.